Human bcr-abl gene has a lethal effect on embryogenesis

Transgenic Res. 1991 Dec;1(1):45-53. doi: 10.1007/BF02512996.

Abstract

The chimaeric bcr-abl oncogene is thought to have a crucial role in the development or maintenance of chronic myelogenous leukaemia. To study this oncogene in a more direct way, the bcr-abl gene encoding the P210 protein under control of the bcr gene promoter was introduced into fertilized one-cell embryos, which were then re-implanted into foster mothers. Our data, obtained after several experiments, demonstrate that no live transgenic progeny could be obtained using this bcr-abl construct. The bcr gene is expressed in the course of embryogenesis and the bcr-abl gene product appears to have a pleiotropic lethal effect during this period of development. In concordance, several gross abnormalities were observed while no evidence of neoplastic formation was found. These results suggest that the bcr-abl encoded protein severely affects the process of normal embryogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Blotting, Northern
  • Embryo, Mammalian / physiology*
  • Fetal Death
  • Fusion Proteins, bcr-abl / genetics*
  • Genes, Lethal*
  • Genes, abl*
  • Humans
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Oligodeoxyribonucleotides
  • Oncogenes*
  • Polymerase Chain Reaction / methods
  • RNA / genetics
  • RNA / isolation & purification
  • Restriction Mapping

Substances

  • Oligodeoxyribonucleotides
  • RNA
  • Fusion Proteins, bcr-abl